179 related articles for article (PubMed ID: 25191656)
1. A clinical, histopathological and immunohistochemical approach to the bewildering diagnosis of keratoacanthoma.
Zargaran M; Baghaei F
J Dent (Shiraz); 2014 Sep; 15(3):91-7. PubMed ID: 25191656
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia.
Lin JH; Lee JY
J Cutan Pathol; 2004 Jul; 31(6):458-61. PubMed ID: 15186435
[TBL] [Abstract][Full Text] [Related]
3. Perforating elastic fibers ('elastic fiber trapping') in the differentiation of keratoacanthoma, conventional squamous cell carcinoma and pseudocarcinomatous epithelial hyperplasia.
Shah K; Kazlouskaya V; Lal K; Molina D; Elston DM
J Cutan Pathol; 2014 Feb; 41(2):108-12. PubMed ID: 24138600
[TBL] [Abstract][Full Text] [Related]
4. Pseudocarcinomatous hyperplasia in anaplastic large cell lymphoma, a mimicker of poorly differentiated squamous cell carcinoma: report of a case and review of the literature.
Price A; Miller JH; Junkins-Hopkins JM
J Cutan Pathol; 2015 Nov; 42(11):863-9. PubMed ID: 26040921
[TBL] [Abstract][Full Text] [Related]
5. [Keratoacanthoma and its clinical variants. Review of the literature and histopathologic analysis of 90 cases].
Seifert A; Nasemann T
Hautarzt; 1989 Apr; 40(4):189-202. PubMed ID: 2659549
[TBL] [Abstract][Full Text] [Related]
6. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
9. CD30+ cell population in common keratoacanthomas: a study of 21 cases.
Fernandez-Flores A
Rom J Morphol Embryol; 2008; 49(2):159-62. PubMed ID: 18516321
[TBL] [Abstract][Full Text] [Related]
10. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma.
Leblebici C; Pasaoglu E; Kelten C; Darakci S; Dursun N
Oncol Lett; 2017 Apr; 13(4):2539-2548. PubMed ID: 28454431
[TBL] [Abstract][Full Text] [Related]
12. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions.
Takai T; Misago N; Murata Y
J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096
[TBL] [Abstract][Full Text] [Related]
13. Lymphomatoid papulosis with pseudocarcinomatous hyperplasia in a 7-year-old girl: a case report.
Xiong J; Ma Y; Chen H; Xu X; Sun J
J Cutan Pathol; 2016 May; 43(5):430-3. PubMed ID: 26531106
[TBL] [Abstract][Full Text] [Related]
14. Synchronous Occurrence of Primary Cutaneous Anaplastic Large Cell Lymphoma and Squamous Cell Carcinoma.
Park JH; Lee JH; Lim Y; Lee YJ; Lee DY
Ann Dermatol; 2016 Aug; 28(4):491-4. PubMed ID: 27489433
[TBL] [Abstract][Full Text] [Related]
15. Cases with a spontaneous regression of an infiltrating non-crateriform keratoacanthoma and squamous cell carcinoma with a keratoacanthoma-like component.
Misago N; Takai T; Murata Y; Nagase K; Narisawa Y
J Dermatol; 2014 May; 41(5):430-4. PubMed ID: 24628407
[TBL] [Abstract][Full Text] [Related]
16. Pseudocarcinomatous Hyperplasia, Squamous Cell Carcinoma, and Keratoacanthoma Associated to Lymphomas of the Skin and External Mucous Membranes: A Case Report and Literature Review.
Jeunon T; Assoni A; Verdolin A
Am J Dermatopathol; 2020 Sep; 42(9):662-672. PubMed ID: 31833842
[TBL] [Abstract][Full Text] [Related]
17. Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification.
Misago N; Inoue T; Koba S; Narisawa Y
J Dermatol; 2013 Jun; 40(6):443-52. PubMed ID: 23414327
[TBL] [Abstract][Full Text] [Related]
18. Crater/ulcerated form of infundibular squamous cell carcinoma: A possible distinct entity as a malignant (or high-grade) counterpart to keratoacanthoma.
Misago N; Inoue T; Nagase K; Tsuruta N; Tara-Hashimoto A; Kimura H; Takahara K; Narita T; Narisawa Y
J Dermatol; 2015 Jul; 42(7):667-73. PubMed ID: 25854192
[TBL] [Abstract][Full Text] [Related]
19. Keratoacanthoma of the inferior lip: review and report of case with spontaneous regression.
Ramos LM; Cardoso SV; Loyola AM; Rocha MA; Durighetto-Júnior AF
J Appl Oral Sci; 2009; 17(3):262-5. PubMed ID: 19466263
[TBL] [Abstract][Full Text] [Related]
20. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
